Results 1 to 10 of about 9,737 (222)

Association Between Escherichia coli Mastitis and Acute Laminitis in Dairy Cows [PDF]

open access: yesAnimals
The objective of this retrospective case-control study was to examine the relationship between E. coli-induced mastitis and acute laminitis in dairy cows. Correspondingly, the medical records of 93 cows diagnosed with E.
Fabian Faustmann   +4 more
doaj   +2 more sources

Incidence and risk factors for recurrence of endocrinopathic laminitis in horses

open access: yesJournal of Veterinary Internal Medicine, 2019
Background Endocrinopathic laminitis is common in horses and ponies, but the recurrence rate of the disease is poorly defined. Objectives To determine the incidence of, and risk factors for, the recurrence of endocrinopathic laminitis.
Melody Anne de Laat   +2 more
exaly   +2 more sources

Methylated tirilazad may mitigate oligofructose-induced laminitis in horses [PDF]

open access: yesFrontiers in Microbiology
Laminitis is a serious health condition that can cause severe pain and lameness in horses. Due to lack of understanding of laminitis, treatments often fail to achieve the desired results.
Maimaiti Tuniyazi   +3 more
doaj   +2 more sources

Effectiveness of acupuncture for equine laminitis: Systematic review and meta-analysis [PDF]

open access: yesVeterinary World
Background and Aim: In the past 20 years, acupuncture has been utilized as an alternative therapy for equine laminitis despite a lack of clinical evidence to support its effectiveness.
Faisal Fikri   +3 more
doaj   +2 more sources

Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis

open access: yesJournal of Veterinary Internal Medicine, 2019
Background Equine endocrinopathic laminitis is common and can be associated with an underlying endocrinopathy, such as equine metabolic syndrome (EMS), pituitary pars intermedia dysfunction (PPID), pasture consumption, or any combination of these factors.
Melody Anne de Laat, Martin N Sillence
exaly   +2 more sources

The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies [PDF]

open access: yesPLoS ONE, 2018
There are no registered veterinary drugs for treating insulin dysregulation and preventing insulin-associated laminitis in horses. Velagliflozin is a sodium-glucose co-transport 2 inhibitor that reduces renal glucose reabsorption, promotes glucosuria ...
Melody Anne de Laat, Martin N Sillence
exaly   +2 more sources

Revealing the Therapeutic Potential of Muscle-Derived Mesenchymal Stem/Stromal Cells: An In Vitro Model for Equine Laminitis Based on Activated Neutrophils, Anoxia–Reoxygenation, and Myeloperoxidase [PDF]

open access: yesAnimals
Laminitis in horses is a crippling condition marked by the deterioration of the dermal–epidermal interface, leading to intense lameness and discomfort, often necessitating euthanasia.
Didier Serteyn   +8 more
doaj   +2 more sources

Plasma amino acid concentrations during experimental hyperinsulinemia in 2 laminitis models

open access: yesJournal of Veterinary Internal Medicine, 2021
Background Endocrinopathic laminitis develops in association with insulin dysregulation, but the role of insulin in the pathogenesis remains unclear. Hyperinsulinemia can cause hypoaminoacidemia, which is associated with integumentary lesions in other ...
Simon M. Stokes   +5 more
doaj   +1 more source

Lamins [PDF]

open access: yesCurrent Biology, 2016
Xie and Burke discuss the roles of lamins in nuclear morphology and the pathological consequences of defects in these nuclear envelope proteins.
Wei, Xie, Brian, Burke
openaire   +2 more sources

Presence of Myeloperoxidase in Lamellar Tissue of Horses Induced by an Euglycemic Hyperinsulinemic Clamp

open access: yesFrontiers in Veterinary Science, 2022
Laminitis is a pathology of the equine digit leading to a failure of the dermo-epidermal interface. Neutrophil activation is recognized as a major factor in SIRS-associated laminitis.
Nazare Storms   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy